Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

Promising new inroads into critical DNA testing has been forecast by Flinders University experts who have applied machine learning to DNA profiling. From medical diagnostics to forensic tests and ...

Delivery, delivery, delivery is the major focus of DNA vaccine research, according to David Weiner, Ph.D., University of Pennsylvania professor and also chair of the recent conference on “DNA Vaccines ...

In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ T-cells at 24 weeks of therapy predicted the subsequent reduction in the ...

Lausanne, Switzerland and London, United Kingdom, February 16, 2005 -- The European Vaccine Effort against HIV/AIDS, today announced that a phase I clinical trial of novel investigational vaccines ...